Wesley Clark, Director at ImmunityBio, Inc. (IBRX), bought 7,000 shares at $2.91 ($20K) on 2023-06-01, disclosed to the SEC on 2023-06-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| RTNB | SELL | 2016-05-18 | $22K | — | Filing → |
| RTNB | SELL | 2016-05-12 | $45K | — | Filing → |
| RTNB | SELL | 2016-05-06 | $12K | — | Filing → |